1. Home
  2. ARQT vs GPI Comparison

ARQT vs GPI Comparison

Compare ARQT & GPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arcutis Biotherapeutics Inc.

ARQT

Arcutis Biotherapeutics Inc.

SELL

Current Price

$27.14

Market Cap

3.3B

Sector

Health Care

ML Signal

SELL

Logo Group 1 Automotive Inc.

GPI

Group 1 Automotive Inc.

SELL

Current Price

$260.73

Market Cap

3.1B

ML Signal

SELL

Company Overview

Basic Information
Metric
ARQT
GPI
Founded
2016
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Retail-Auto Dealers and Gas Stations
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
3.3B
3.1B
IPO Year
2020
1997

Fundamental Metrics

Financial Performance
Metric
ARQT
GPI
Price
$27.14
$260.73
Analyst Decision
Buy
Buy
Analyst Count
8
12
Target Price
$40.38
★ $324.92
AVG Volume (30 Days)
★ 2.4M
176.3K
Earning Date
11-04-2026
10-28-2026
Dividend Yield
N/A
★ 0.85%
EPS Growth
★ 88.79
N/A
EPS
0.09
★ 28.09
Revenue
$376,072,000.00
★ $11,123,721,000.00
Revenue This Year
$44.19
N/A
Revenue Next Year
$29.31
$4.30
P/E Ratio
$314.67
★ $9.24
Revenue Growth
★ 91.34
2.17
52 Week Low
$19.30
$224.65
52 Week High
$34.80
$429.00

Technical Indicators

Market Signals
Indicator
ARQT
GPI
Relative Strength Index (RSI) 44.15 51.65
Support Level $25.08 $247.88
Resistance Level $28.54 $345.21
Average True Range (ATR) 1.58 12.66
MACD -0.48 -0.02
Stochastic Oscillator 19.64 43.51

Price Performance

Historical Comparison
ARQT
GPI

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs. Its current portfolio is comprised of differentiated topical and systemic treatments with potential to treat immune-mediated dermatological diseases and conditions. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population. The Company has one reportable segment relating to the development and commercialization of treatments for dermatological diseases.

About GPI Group 1 Automotive Inc.

Group 1 owns and operates 33 collision centers and over 255 automotive dealerships in the US and the UK, offering 38 brands of automobiles altogether. Slightly over half of the stores are in the US with locations mostly in metropolitan areas in 17 states in the Northeast, Southeast, Midwest, and California. Texas alone contributed 31.6% of new-vehicle unit volume in 2025 and the UK 27.6%. Texas, Massachusetts, and California combined was 45.4%. Revenue in 2025 totaled $22.6 billion. The firm entered the UK in 2007 and has 104 stores there contributing about 26% of total revenue. Group 1 was founded in 1995 and is based in Houston.

Share on Social Networks: